This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Infectious Lung Disorder
Information about Infectious Lung Disorder: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Infectious Lung Disorder
Most recent studies have shown that Infectious Lung Disorder shares some biological mechanisms with acquired-immunodeficiency-syndrome, bacterial-infections, cystic-fibrosis, fibrosis, immunologic-deficiency-syndromes, infective-disorder, inflammation, lung-diseases, lung-diseases-fungal, malignant-neoplasms, mycobacterium-infections, mycobacterium-infections-nontuberculous, pneumonia, pneumonia-bacterial, pneumonia-pneumocystis-carinii, pseudomonas-infections, respiratory-tract-infections, systemic-infection, tuberculosis, tuberculosis-pulmonary.
Among the many pathways, these few ones have gauged particular interests from scientists studying Infectious Lung Disorder, and have been seen in publications frequently: Biofilm Formation, Cell Death, Chemotaxis, Coagulation, Cytokine Production, Dehiscence, Drug Resistance, Granuloma Formation, Hypersensitivity, Immune Response, Inflammatory Response, Innate Immune Response, Localization, Macrophage Activation, Pathogenesis, Phagocytosis, Quorum Sensing, Secretion, Transport, Virulence
Quite a number of genes have been found to play important roles in Infectious Lung Disorder, such as ALB, CALCA, CCL2, CD4, CD8A, CFTR, CRP, ELANE, IFNG, IL10, IL4, IL6, NTM, SLC9A6, TLR2, TLR4, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.